How many insider declarations has Thomas Jonassen filed?

Thomas Jonassen has filed 4 public insider declarations with FIN-FSA.

What is Thomas Jonassen's role?

Thomas Jonassen's reported role is not specified by the regulator across the filings.

Which companies does Thomas Jonassen report trades for?

Thomas Jonassen reports trades for SynAct Pharma AB.

← Executives ★ Sign in to follow

TJ

Thomas Jonassen

·FIN-FSA

SynAct Pharma AB

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

0

T+90 hit rate

0%

T+90 mean return

-17.6%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

No signal scores available.

Discover the complete record of transactions filed by Thomas Jonassen. Director active across 1 company, notably SynAct Pharma AB. Aggregated, 4 disclosures have been recorded. Activity tracked since 6 January 2021. The latest transaction was disclosed on 19 December 2025 (Purchase). Regulator: FIN-FSA. The full history is free.

Companies and markets linked to Thomas Jonassen

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

SynAct Pharma AB (FI)

Declarations4 total

●

Thomas Jonassen

Annan ledande befattningshavareExecutives19 Dec 2025SynAct Pharma AB

€6,62724FI-SE ↗

3,529 shares@ €1.87780.0076% mcap100.0% of flowAktieSE0008241491FI:A003V108-1

●

Thomas Jonassen

Styrelseledamot, Annan ledande befattningshavareExecutives6 Jan 2021SynAct Pharma AB

0FI-SE ↗

1,456,263 shares0AktieSE0008241491FI:A001P435-2

●

Thomas Jonassen

Styrelseledamot, Annan ledande befattningshavareExecutives6 Jan 2021SynAct Pharma AB

0FI-SE ↗

2,296,651 shares0AktieSE0008241491FI:A001P434-1

●

Thomas Jonassen

Styrelseledamot, Annan ledande befattningshavareExecutives6 Jan 2021SynAct Pharma AB

0FI-SE ↗

2,296,651 shares0AktieSE0008241491FI:A001P431-1

4 of 4 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

TJ

Thomas Jonassen

·FIN-FSA

SynAct Pharma AB

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

0

T+90 hit rate

0%

T+90 mean return

-17.6%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

No signal scores available.

Discover the complete record of transactions filed by Thomas Jonassen. Director active across 1 company, notably SynAct Pharma AB. Aggregated, 4 disclosures have been recorded. Activity tracked since 6 January 2021. The latest transaction was disclosed on 19 December 2025 (Purchase). Regulator: FIN-FSA. The full history is free.